The pediatric sepsis biomarker risk model
- PMID: 23025259
- PMCID: PMC3682273
- DOI: V体育2025版 - 10.1186/cc11652
The pediatric sepsis biomarker risk model
Abstract
Introduction: The intrinsic heterogeneity of clinical septic shock is a major challenge. For clinical trials, individual patient management, and quality improvement efforts, it is unclear which patients are least likely to survive and thus benefit from alternative treatment approaches. A robust risk stratification tool would greatly aid decision-making. The objective of our study was to derive and test a multi-biomarker-based risk model to predict outcome in pediatric septic shock. VSports手机版.
Methods: Twelve candidate serum protein stratification biomarkers were identified from previous genome-wide expression profiling. To derive the risk stratification tool, biomarkers were measured in serum samples from 220 unselected children with septic shock, obtained during the first 24 hours of admission to the intensive care unit V体育安卓版. Classification and Regression Tree (CART) analysis was used to generate a decision tree to predict 28-day all-cause mortality based on both biomarkers and clinical variables. The derived tree was subsequently tested in an independent cohort of 135 children with septic shock. .
Results: The derived decision tree included five biomarkers. In the derivation cohort, sensitivity for mortality was 91% (95% CI 70 - 98), specificity was 86% (80 - 90), positive predictive value was 43% (29 - 58), and negative predictive value was 99% (95 - 100). When applied to the test cohort, sensitivity was 89% (64 - 98) and specificity was 64% (55 - 73) V体育ios版. In an updated model including all 355 subjects in the combined derivation and test cohorts, sensitivity for mortality was 93% (79 - 98), specificity was 74% (69 - 79), positive predictive value was 32% (24 - 41), and negative predictive value was 99% (96 - 100). False positive subjects in the updated model had greater illness severity compared to the true negative subjects, as measured by persistence of organ failure, length of stay, and intensive care unit free days. .
Conclusions: The pediatric sepsis biomarker risk model (PERSEVERE; PEdiatRic SEpsis biomarkEr Risk modEl) reliably identifies children at risk of death and greater illness severity from pediatric septic shock. PERSEVERE has the potential to substantially enhance clinical decision making, to adjust for risk in clinical trials, and to serve as a septic shock-specific quality metric. VSports最新版本.
Figures


"V体育平台登录" References
-
- Czaja AS, Zimmerman JJ, Nathens AB. Readmission and late mortality after pediatric severe sepsis. Pediatrics. 2009;16:849–857. doi: 10.1542/peds.2008-0856. - DOI (V体育平台登录) - PubMed
-
- Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;16:296–327. doi: 10.1097/01.CCM.0000298158.12101.41. - DOI - PubMed
-
- Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Resp Crit Care Med. 2003;16:695–701. doi: 10.1164/rccm.200207-682OC. - DOI (VSports最新版本) - PubMed
-
- Marshall JC. Sepsis: rethinking the approach to clinical research. J Leukoc Biol. 2008;16:471–482. - PubMed
"VSports在线直播" Publication types
MeSH terms
- Actions (V体育ios版)
- Actions (V体育2025版)
- "VSports app下载" Actions
- V体育平台登录 - Actions
- VSports手机版 - Actions
- VSports手机版 - Actions
- Actions (V体育2025版)
Substances (V体育平台登录)
- "V体育ios版" Actions
Grants and funding (VSports在线直播)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical